IDH1 status was known only in U87 cell line (wild type); in high-grade gliomas, Buckingham has shown high levels of glutamate release by tumor cells in an experimental model of brain tumor-associated epilepsy [35]. Here, IDH1 is linked to central nervous system cancer.